| FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats [S] S Cipriani, A Mencarelli, G Palladino, S Fiorucci Journal of lipid research 51 (4), 771-784, 2010 | 449 | 2010 |
| Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders S Fiorucci, A Mencarelli, G Palladino, S Cipriani Trends in pharmacological sciences 30 (11), 570-580, 2009 | 365 | 2009 |
| The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis S Cipriani, A Mencarelli, MG Chini, E Distrutti, B Renga, G Bifulco, ... PloS one 6 (10), e25637, 2011 | 362 | 2011 |
| Selected food intake and risk of endometriosis F Parazzini, F Chiaffarino, M Surace, L Chatenoud, S Cipriani, ... Human Reproduction 19 (8), 1755-1759, 2004 | 299 | 2004 |
| Modulation of intestinal microbiota by the probiotic VSL# 3 resets brain gene expression and ameliorates the age-related deficit in LTP E Distrutti, JA O’Reilly, C McDonald, S Cipriani, B Renga, MA Lynch, ... PloS one 9 (9), e106503, 2014 | 240 | 2014 |
| The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of GPBAR1 rescues mice from murine colitis M Biagioli, A Carino, S Cipriani, D Francisci, S Marchianò, P Scarpelli, ... The Journal of Immunology 199 (2), 718-733, 2017 | 222 | 2017 |
| Bile acid-activated receptors in the treatment of dyslipidemia and related disorders S Fiorucci, S Cipriani, F Baldelli, A Mencarelli Progress in lipid research 49 (2), 171-185, 2010 | 167 | 2010 |
| The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis A Mencarelli, B Renga, M Migliorati, S Cipriani, E Distrutti, L Santucci, ... The Journal of Immunology 183 (10), 6657-6666, 2009 | 167 | 2009 |
| Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice S Cipriani, D Francisci, A Mencarelli, B Renga, E Schiaroli, C D’Amore, ... Circulation 127 (21), 2114-2124, 2013 | 136 | 2013 |
| VSL# 3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation A Mencarelli, S Cipriani, B Renga, A Bruno, C D'Amore, E Distrutti, ... Public Library of Science 7 (9), e45425, 2012 | 128 | 2012 |
| Probiotics VSL# 3 protect against development of visceral pain in murine model of irritable bowel syndrome E Distrutti, S Cipriani, A Mencarelli, B Renga, S Fiorucci PloS one 8 (5), e63893, 2013 | 127 | 2013 |
| Counter-regulatory role of bile acid activated receptors in immunity and inflammation S Fiorucci, S Cipriani, A Mencarelli, B Renga, E Distrutti, F Baldelli Current molecular medicine 10 (6), 579-595, 2010 | 125 | 2010 |
| BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis A Carino, S Cipriani, S Marchianò, M Biagioli, C Santorelli, A Donini, ... Scientific Reports 7 (1), 42801, 2017 | 117 | 2017 |
| Mesenchymal cells from human amniotic fluid survive and migrate after transplantation into adult rat brain S Cipriani, D Bonini, E Marchina, I Balgkouranidou, L Caimi, GG Zucconi, ... Cell Biology International 31 (8), 845-850, 2007 | 116 | 2007 |
| ‘One night’sleep deprivation stimulates hippocampal neurogenesis GG Zucconi, S Cipriani, I Balgkouranidou, R Scattoni Brain research bulletin 69 (4), 375-381, 2006 | 116 | 2006 |
| Pregnane-X-receptor mediates the anti-inflammatory activities of rifaximin on detoxification pathways in intestinal epithelial cells A Mencarelli, M Migliorati, M Barbanti, S Cipriani, G Palladino, E Distrutti, ... Biochemical pharmacology 80 (11), 1700-1707, 2010 | 115 | 2010 |
| Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation A Mencarelli, E Distrutti, B Renga, C D'Amore, S Cipriani, G Palladino, ... PLoS One 6 (7), e22978, 2011 | 104 | 2011 |
| Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA S Fiorucci, S Cipriani, A Mencarelli, F Baldelli, G Bifulco, A Zampella Mini reviews in medicinal chemistry 11 (9), 753-762, 2011 | 101 | 2011 |
| The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation B Renga, A Mencarelli, S Cipriani, C D'Amore, A Carino, A Bruno, ... PLoS One 8 (1), e54472, 2013 | 98 | 2013 |
| Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands C Festa, B Renga, C D’Amore, V Sepe, C Finamore, S De Marino, ... Journal of medicinal chemistry 57 (20), 8477-8495, 2014 | 87 | 2014 |
